Related News

FDA Approves Keytruda for Advanced NSCLC


Approved for use with PD-L1 IHC 22C3 pharmDx test

Palliative Radiotherapy Often Overused in Stage IV NSCLC


Not proven to further improve symptoms or quality of life; can have significant side effects

FDA Approves New Combo Therapy for Melanoma


Yervoy and Opdivo previously approved individually to treat melanoma

Frequently Asked Questions